Minerva Neurosciences, Inc. Gains 58.19%

Fri, Aug 26, 2022 at 07:02 PM
Minerva Neurosciences, Inc. Gains 58.19%

Minerva Neurosciences, Inc. (NERV:NASDAQ) shot up at $10.33, representing a gain of 58.2%. On Fri, Aug 26, 2022, NERV:NASDAQ hit a New 2-Week High of $10.33. The stock got featured on our News Catalysts scanner on Mon, Aug 22, 2022 at 08:32 AM in the 'BIOTECH' category. From Fri, Aug 12, 2022, the stock recorded 60.00% Up Days and 63.64% Green Days

About Minerva Neurosciences, Inc. (NERV:NASDAQ)

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.